Pharmafile Logo

Stratophase appoints Remy Martin as Business Development Manager

August 9, 2017 – BioManufacturing –

Romsey, UK; 9 August 2017. Stratophase, the UK-based biopharmaceutical services and technology company, has today announced the appointment of Remy Martin as Business Development Manager.

Remyís main responsibility will be to build and manage the companyís growing portfolio of Ranger bioprocessing contract services. He will focus primarily on the European market and report to Stratophase CEO Simon Saxby.

Remy brings to Stratophase a wealth of experience and knowledge of upstream process development, process control and sensor technologies.

He joins the company from the University of Bristol, where he was employed as a Post-Doctoral Research Associate. Prior to that, Remy worked as a Bioreactor Specialist at Applikon Biotechnology UK, providing bespoke bioreactor control solutions.

Remy has a PhD in Biochemistry from the University of Bristol and an MBiol in Molecular & Cellular Biology from the University of Bath.

Commenting on Remy Martinís appointment, CEO Simon Saxby said: ‘Remyís enthusiasm for, and experience in, bioreactor control fit perfectly with the on-going development of Ranger© adaptive control contract services and their take-up by the global biopharma industry’.

Stratophase
enquiries@stratophase.com
Unit 10a, The Quadrangle, Premier Way , Romsey, Hampshire, SO51 9DL